BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Nov 12, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Plavix clopidogrel regulatory update

Sanofi said in its 3Q12 earnings that Japan approved sNDAs for Plavix clopidogrel to treat patients with peripheral artery disease (PAD) and with ST-elevated myocardial infarction. The product is already approved in Japan to treat stable angina/old...

Read the full 164 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >